Sector Investors News and Insights

AZN.XLON

The volatility of options and the predicted stock price moves based on implied earnings for today, July 25, 2024.

XLI Industrials, XLV Health Care, XLY Consumer Discretionary / / , , ,

Read More: https://www.tipranks.com/news/options-volatility-and-implied-earnings-moves-today-july-25-2024?utm_source=alphanewsstream.com&utm_medium=referral

The volatility of options and the predicted stock price moves based on implied earnings for today, July 25, 2024. Read More »

, , ,

Could this AI growth stock, backed by Google, become the next Nvidia?

XLC Communication Services, XLF Financials, XLK Technology, XLV Health Care / / , , , , , , , , , , ,

A healthcare company called Tempus AI (NASDAQ: TEM) that utilizes artificial intelligence (AI) to assist doctors in customizing patient care became a publicly traded company on 14 June. Established in 2015…

Could this AI growth stock, backed by Google, become the next Nvidia? Read More »

, , , , , , , , , , ,

A Google-supported artificial intelligence growth stock could be the next Nvidia.

XLC Communication Services, XLF Financials, XLK Technology, XLV Health Care / / , , , , , , , , , , ,

On June 14, Tempus AI (NASDAQ: TEM), a healthcare company that utilizes artificial intelligence to assist doctors in customizing patient care, went public as a promising new growth stock. Established in 2015…

A Google-supported artificial intelligence growth stock could be the next Nvidia. Read More »

, , , , , , , , , , ,

Could this AI growth stock supported by Google be the next Nvidia?

XLC Communication Services, XLF Financials, XLK Technology, XLV Health Care / / , , , , , , , , , , ,

Tempus AI, a healthcare company utilizing artificial intelligence to assist doctors in customizing patient care, became a publicly traded stock on June 14th. Established in 2015…

Could this AI growth stock supported by Google be the next Nvidia? Read More »

, , , , , , , , , , ,

The GSK share price dropped by 10% in a single day, making it appear to be a rare opportunity to buy at a discounted price.

XLB Materials, XLF Financials, XLP Consumer Staples, XLV Health Care / / , , , , , , , , , , , , , , , ,

The speaker enjoys purchasing stocks when they are down, so they bought shares of GSK right away when they saw the price had dropped by 9.53% on Monday. They have a habit of averaging down when investing.

The GSK share price dropped by 10% in a single day, making it appear to be a rare opportunity to buy at a discounted price. Read More »

, , , , , , , , , , , , , , , ,

The British Gas executive’s salary of 8.2 million pounds is being questioned by Nils Pratley.

XLU Utilities, XLV Health Care / / , , , ,

The increase in wholesale energy prices has contributed to the rise in share price, which the individual cannot control. Shareholders reacted strongly, with a 35% rebellion, towards AstraZeneca’s actions.

The British Gas executive’s salary of 8.2 million pounds is being questioned by Nils Pratley. Read More »

, , , ,

TAGRISSO (osimertinib) showed an 84% decrease in the likelihood of disease progression or death in patients with unresectable, Stage III EGFR-mutated lung cancer compared to placebo in the LAURA Phase III trial.

XLV Health Care / / , ,

Positive outcomes from the LAURA Phase III trial revealed that AstraZeneca’s TAGRISSO (osimertinib) displayed a significant and significantly beneficial enhancement in progression-free.

TAGRISSO (osimertinib) showed an 84% decrease in the likelihood of disease progression or death in patients with unresectable, Stage III EGFR-mutated lung cancer compared to placebo in the LAURA Phase III trial. Read More »

, ,

© 2025 ETF Sector

Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com